,,iv #aai? ,,congress #a/ ,session ,h4 ,,res4 #ijc ,,9 ,,! ,,h\se ,,( ,,repres5tatives ,novemb] #bj1 #bjbe,mr4 ,tonko 7= himself & ,mrs4 ,mill]-,meeks7 submitt$ ! foll[+ resolution2 :i* 0 ref]r$ to ! ,committee on ,en]gy & ,comm]ce ,,resolution ,express+ support = ! designation ( ,novemb] z ,complex ,regional ,pa9 ,syndrome & ,reflex ,sympa!tic ,dy/rophy ,syndrome ,aw>5ess ,mon?4 ,:]eas ,complex ,regional ,pa9 ,syndrome1 also kn[n z ,reflex ,sympa!tic ,dy/rophy ,syndrome1 is a r>e1 neuro-inflammatory syndrome *>act]iz$ by int5se *ronic pa91 swell+1 vascul> *anges1 & functional impairm5t ( ! limbs t may result f simple trauma1 injury1 infection1 or surg]y t c lead to disability2 ,:]eas ,complex ,regional ,pa9 ,syndrome c become debilitat+ unless diagnos$ e>ly & treat$ appropriately2 ,:]eas al?\gh ,complex ,regional ,pa9 ,syndrome 0 fir/ id5tifi$ dur+ ! ,am]ican ,civil ,w>1 x rema9s an obscure & poorly und]/ood condition = :i* !re is no s+le te/ = diagnosis1 & !re is no cure2 ,:]eas ,complex ,regional ,pa9 ,syndrome is m common 9 wom5 ?an m5 ) a ratio ( #c4e3a1 ) peak incid5ce 9 middle-ag$ & old] adults1 especially po/ m5opausal wom52 ,:]eas ! incid5ce ( ,complex ,regional ,pa9 ,syndrome is l[ worldwide1 ) regional rates g5]ally betwe5 #e & #bi p] #ajj1jjj individuals1 high] 9 wom5 & old] adults1 & ev5 l[] 9 *ildr52 ,:]eas individuals ) ,complex ,regional ,pa9 ,syndrome1 l _m o!r r>e disord]s1 exp]i5ce *all5ges ) obta9+ a diagnosis1 limit$ treatm5t options1 & difficulty f9d+ & access+ treatm5t c5t]s & physicians ) exp]tise 9 ,complex ,regional ,pa9 ,syndrome2 ,:]eas because ! disord] affects multiple sy/ems ( ! body1 a pati5t ) ,complex ,regional ,pa9 ,syndrome (t5 requires access to c>e f exp]ts across a range ( m$ical specialties2 ,:]eas1 to date1 !re is no treatm5t = ,complex ,regional ,pa9 ,syndrome t is approv$ by ! ,food & ,drug ,adm9i/ration 79 ?is resolution ref]r$ to z ! ,,fda72 ,:]eas !re is a critical ne$ = rese>* & developm5t to advance treatm5ts = ,complex ,regional ,pa9 ,syndrome2 ,:]eas1 z a result ( ! ,orphan ,drug ,act1 !re h be5 important advances 9 rese>* on & treatm5t = r>e diseases1 includ+ developm5t ef=ts 9 ,complex ,regional ,pa9 ,syndrome2 ,:]eas ! ,,fda e/abli%$ ! ,accel]at$ ,approval ,pa?way 9 #aiib & ,congress codifi$ ! pa?way 9 #bjab2 ,:]eas ! ,accel]at$ ,approval ,pa?way is an important pa?way = r>e & ultr>>e diseases z x all[s = e>li] approval ( drugs t treat s]i\s conditions1 & fill an unmet m$ical ne$2 ,:]eas ,congress & ! ,,fda h affirm$ ! importance ( incorporat+ ! pati5t p]spective ?r\gh\t ! drug review process ?r\gh ! ,,fda's ,pati5t-,focus$ ,drug ,developm5t program2 ,:]eas ! ,reflex ,sympa!tic ,dy/rophy ,syndrome ,association1 a nonpr(it organization f\nd$ 9 #aihd to provide support1 education1 & hope to all affect$ by ! pa9 & disability ( ,,crps_/,,rsd1 :ile driv+ rese>* to develop bett] treatm5ts & a cure = ,complex ,regional ,pa9 ,syndrome2 & ,:]eas ,complex ,regional ,pa9 ,syndrome & ,reflex ,sympa!tic ,dy/rophy ,syndrome ,aw>5ess ,mon? is expect$ to be obs]v$ 9 ! ,unit$ ,/ates = ye>s to come1 provid+ hope & in=mation = pati5ts1 c>egiv]s1 & families ar\nd ! c\ntry3 ,n[1 !re=e1 be x ,t ! ,h\se ( ,repres5tatives-- 7#a7 expresses support = ! designation ( ,complex ,regional ,pa9 ,syndrome & ,reflex ,sympa!tic ,dy/rophy ,syndrome ,aw>5ess ,mon?2 & 7#b7 recognizes ! importance (1 ) respect to ,complex ,regional ,pa9 ,syndrome & ,reflex ,sympa!tic ,dy/rophy ,syndrome ,aw>5ess ,mon?-- 7,a7 improv+ aw>5ess2 7,b7 enc\rag+ accurate & e>ly diagnosis2 7,c7 advanc+ rese>*2 7,d7 develop+ new treatm5ts1 diagno/ics1 & cures2 & 7,e7 id5tify+ regulatory pa?ways = drug developm5t ( ultr>>e diseases l ,complex ,regional ,pa9 ,syndrome & ,reflex ,sympa!tic ,dy/rophy ,syndrome4